Return On Assets in % of Monopar Therapeutics from Q3 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Monopar Therapeutics quarterly/annual Return On Assets history and growth rate from Q3 2018 to Q3 2025.
  • Monopar Therapeutics Return On Assets for the quarter ending September 30, 2025 was -24.8 %, a 71.7% increase year-over-year.
  • Monopar Therapeutics annual Return On Assets for 2024 was -75.6 %, a 14.3% increase from 2023.
  • Monopar Therapeutics annual Return On Assets for 2023 was -88.2 %, a 31% decline from 2022.
  • Monopar Therapeutics annual Return On Assets for 2022 was -67.3 %, a 72.7% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)

Monopar Therapeutics Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -24.8 +63 +71.7% Jul 1, 2025 Sep 30, 2025
Q2 2025 -39.5 +49.5 +55.6% Apr 1, 2025 Jun 30, 2025
Q1 2025 -51.5 +35 +40.4% Jan 1, 2025 Mar 31, 2025
Q4 2024 -75.6 +12.6 +14.3% Oct 1, 2024 Dec 31, 2024
Q3 2024 -87.8 -1.53 -1.77% Jul 1, 2024 Sep 30, 2024
Q2 2024 -89 -9.27 -11.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -86.5 -11.9 -15.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -88.2 -20.9 -31% Oct 1, 2023 Dec 31, 2023
Q3 2023 -86.2 -27.2 -46% Jul 1, 2023 Sep 30, 2023
Q2 2023 -79.7 -26.5 -49.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -74.6 -29.4 -65% Jan 1, 2023 Mar 31, 2023
Q4 2022 -67.3 -28.3 -72.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -59.1 -20.9 -54.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -53.2 -17 -47% Apr 1, 2022 Jun 30, 2022
Q1 2022 -45.2 -6.73 -17.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -39 +2.58 +6.21% Oct 1, 2021 Dec 31, 2021
Q3 2021 -38.1 -0.43 -1.14% Jul 1, 2021 Sep 30, 2021
Q2 2021 -36.2 +4.41 +10.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -38.5 +4.21 +9.86% Jan 1, 2021 Mar 31, 2021
Q4 2020 -41.6 +14 +25.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -37.7 +26.5 +41.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -40.6 +15.5 +27.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -42.7 +4.57 +9.67% Jan 1, 2020 Mar 31, 2020
Q4 2019 -55.6 -18.4 -49.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -64.1 -31.7 -97.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -56.2 Apr 1, 2019 Jun 30, 2019
Q1 2019 -47.3 Jan 1, 2019 Mar 31, 2019
Q4 2018 -37.2 Oct 1, 2018 Dec 31, 2018
Q3 2018 -32.4 Jul 1, 2018 Sep 30, 2018

Monopar Therapeutics Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -75.6 +12.6 +14.3% Jan 1, 2024 Dec 31, 2024
2023 -88.2 -20.9 -31% Jan 1, 2023 Dec 31, 2023
2022 -67.3 -28.3 -72.7% Jan 1, 2022 Dec 31, 2022
2021 -39 +2.58 +6.21% Jan 1, 2021 Dec 31, 2021
2020 -41.6 +14 +25.2% Jan 1, 2020 Dec 31, 2020
2019 -55.6 -16.2 -41.2% Jan 1, 2019 Dec 31, 2019
2018 -39.4 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.